BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38519280)

  • 21. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.
    Hassanzadeh E; Glazer DI; Dunne RM; Fennessy FM; Harisinghani MG; Tempany CM
    Abdom Radiol (NY); 2017 Jan; 42(1):278-289. PubMed ID: 27522352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
    Schimmöller L; Quentin M; Arsov C; Lanzman RS; Hiester A; Rabenalt R; Antoch G; Albers P; Blondin D
    Eur Radiol; 2013 Nov; 23(11):3185-90. PubMed ID: 23756958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.
    Lin WC; Muglia VF; Silva GE; Chodraui Filho S; Reis RB; Westphalen AC
    Br J Radiol; 2016 Jun; 89(1062):20151056. PubMed ID: 27007818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
    Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
    Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
    Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
    Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
    Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
    Padhani AR; Weinreb J; Rosenkrantz AB; Villeirs G; Turkbey B; Barentsz J
    Eur Urol; 2019 Mar; 75(3):385-396. PubMed ID: 29908876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
    Moore CM; Kasivisvanathan V; Eggener S; Emberton M; Fütterer JJ; Gill IS; Grubb Iii RL; Hadaschik B; Klotz L; Margolis DJ; Marks LS; Melamed J; Oto A; Palmer SL; Pinto P; Puech P; Punwani S; Rosenkrantz AB; Schoots IG; Simon R; Taneja SS; Turkbey B; Ukimura O; van der Meulen J; Villers A; Watanabe Y;
    Eur Urol; 2013 Oct; 64(4):544-52. PubMed ID: 23537686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PI-RADS Version 2: A Pictorial Update.
    Purysko AS; Rosenkrantz AB; Barentsz JO; Weinreb JC; Macura KJ
    Radiographics; 2016; 36(5):1354-72. PubMed ID: 27471952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
    Durmus T; Baur A; Hamm B
    Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting.
    Raeside M; Low A; Cohen P; Sutherland P; Gormly K
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):487-494. PubMed ID: 30951248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
    Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C
    Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence.
    Scialpi M; Martorana E; Scialpi P; Scalera GB; Belatti E; Aisa MC; D'Andrea A; Mancioli FM; DI Marzo A; Trippa F; DI Blasi A
    Anticancer Res; 2023 Jan; 43(1):297-303. PubMed ID: 36585156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
    Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.
    Bazargani S; Feibus AH; Elshafei A; Al-Toubat M; Gopireddy DR; Gautam S; Barwari S; Henderson R; Lall C; Balaji KC; Bandyk M
    Urol Oncol; 2023 Mar; 41(3):145.e1-145.e5. PubMed ID: 36496342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance after prostate focal therapy.
    Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
    World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting.
    Brizmohun Appayya M; Adshead J; Ahmed HU; Allen C; Bainbridge A; Barrett T; Giganti F; Graham J; Haslam P; Johnston EW; Kastner C; Kirkham APS; Lipton A; McNeill A; Moniz L; Moore CM; Nabi G; Padhani AR; Parker C; Patel A; Pursey J; Richenberg J; Staffurth J; van der Meulen J; Walls D; Punwani S
    BJU Int; 2018 Jul; 122(1):13-25. PubMed ID: 29699001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.